As members are aware, the next step is to meet “in person” when working from home guidelines are relaxed in order to conduct a “Hackathon” to make progress towards an ecosystem and regulatory framework for companies to work within to ensure access to advanced diagnostics and encourage dialogue and further understanding with the NHS and the Genomics Hubs.
We hope to re-schedule this in late February/ Early March.
Details of guests and speakers will be shared as soon as possible, MRC who presented at our last meeting hope to attend to discuss the Cancer Summit and engagement with industry for part of the meeting.
On Wednesday 19 January – 10.00-11.30 – BIVDA and EUCOPE are jointly hosting a Roundtable event on Advanced Diagnostics, which all of our Genomics WP members have already received an invitation for. EUCOPE’s members have also received an invitation in the same manner.
Please join us for this discussion and please come prepared with your experiences and thoughts, we are looking forward to discussing them.
The format of this is a panel and audience event, however it is intended to be an informal and comfortable open discussion.
The panellists are open to understanding our views and have been asked to prepare their thoughts on the questions below to open the conversation.
How can the NHS support an appropriate R&D ecosystem for advanced diagnostics?
- How appropriate regulatory pathways can be established that are tailored for advanced diagnostic tests?
- How fit-for-purpose assessment frameworks and predictable reimbursement can expedite market access and registration for products?
Our panellists are;
Angela Douglas MBE – Deputy Chief Scientific Officer, NHSE
Mike Messenger – MHRA
Dame Anna Dominiczak DBE MD – UKHSA
Sarah Byron – CHTE Programme Director – NICE
Catherine Cargo – Consultant (Leeds)
Mike Hubank – Head of Clinical Genomics (Royal Marsden)
Benjamin Gannon – Guardant Health
We are really excited for this discussion and the expected outcomes from this meeting, and look forward to seeing you there!